Renal insufficiency
Chronic renal failure (CRF) refers to a slowly progressive renal impairment caused by various kidney diseases, which eventually leads to uremia and complete loss of renal function, causing a series of clinical symptoms and a clinical syndrome consisting of biochemical, endocrine and other metabolic disorders. The interval from the onset of the primary disease to the onset of renal insufficiency can be several years to more than ten years. Chronic renal failure is a serious stage of renal insufficiency.
-
Site of disease:
kidney -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Hyperuric acid metabolism lethargy sleepiness blood pressure drop chronic renal insufficiency -
Concurrent disease:
Related Drugs
Recombinant human growth hormone for injection
Indication: It is used for growth hormone deficiency in children and adults, Turner's syndrome, growth failure caused by chronic renal failure in children, hypermetabolic state (negative nitrogen balance) after surgery and trauma, burns, and sepsis.
Manufacturer:
Shenzhen Kexing Pharmaceutical Co., Ltd.
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Manufacturer:
Chengdu DIAO Jiuhong Pharmaceutical Factory
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Manufacturer:
NCPC Genetech BIOTECHNOLOGY Co., Ltd.
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Manufacturer:
NCPC Genetech BIOTECHNOLOGY Co., Ltd.
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Allopurinol Tablets
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive production of uric acid. 2. Patients with recurrent or chronic gout. 3. Gout stones. 4. Uric acid kidney stones and/or uric acid nephropathy. 5. Hyperuricemia with renal insufficiency.
Allopurinol Tablets
Indication: It is used for ① primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; ② recurrent or chronic gout; ③ tophi; ④ uric acid kidney stones and (or) uric acid nephropathy; ⑤ hyperuricemia with renal insufficiency.
Manufacturer:
Han Hui Pharmaceuticals Company Limited
Allopurinol Tablets
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:
Matrix Laboratories (Xiamen) Ltd.
Related Ingredients
-
Somatonorm list
82030-87-3 -
Erythropoietin list
11096-26-7 -
Allopurinol list
315-30-0